Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2010 1
2017 2
2018 1
2019 1
2021 3
2022 2
2023 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Aberrant lipid metabolism as a therapeutic target in liver cancer.
Pope ED 3rd, Kimbrough EO, Vemireddy LP, Surapaneni PK, Copland JA 3rd, Mody K. Pope ED 3rd, et al. Among authors: copland ja 3rd. Expert Opin Ther Targets. 2019 Jun;23(6):473-483. doi: 10.1080/14728222.2019.1615883. Epub 2019 May 10. Expert Opin Ther Targets. 2019. PMID: 31076001 Free PMC article. Review.
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer.
Kase AM, Gleba J, Miller JL, Miller E, Petit J, Barrett MT, Zhou Y, Parent EE, Cai H, Knight JA, Orme J, Reynolds J, Durham WF, Metz TM, Meurice N, Edenfield B, Alasonyalilar Demirer A, Bilgili A, Hickman PG, Pawlush ML, Marlow L, Wickland DP, Tan W, Copland JA 3rd. Kase AM, et al. Among authors: copland ja 3rd. Mol Cancer Ther. 2024 Jun 4;23(6):823-835. doi: 10.1158/1535-7163.MCT-23-0296. Mol Cancer Ther. 2024. PMID: 38442920
The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth.
Shukla S, Riveros C, Al-Toubat M, Chardon-Robles J, Osumi T, Serrano S, Kase AM, Petit JL, Meurice N, Gleba J, Copland JA 3rd, Chauhan J, Fletcher S, Balaji KC. Shukla S, et al. Among authors: copland ja 3rd. Cancers (Basel). 2023 Jul 28;15(15):3851. doi: 10.3390/cancers15153851. Cancers (Basel). 2023. PMID: 37568667 Free PMC article.
Human iPSC-derived MSCs induce neurotrophic effects and improve metabolic activity in acute neuronal injury models.
Kawatani K, Omana Suarez G, Perkerson RB 3rd, Parent EE, Nambara T, Knight JA, Parsons TM, Gupta K, Shue F, Alnobani A, Vibhute P, Cai H, Guerrero-Cázares H, Copland JA 3rd, Quiñones-Hinojosa A, Kanekiyo T. Kawatani K, et al. Among authors: copland ja 3rd. J Neurosci. 2024 Nov 4:e0606242024. doi: 10.1523/JNEUROSCI.0606-24.2024. Online ahead of print. J Neurosci. 2024. PMID: 39496487
Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY).
Boughey JC, Suman VJ, Yu J, Santo K, Sinnwell JP, Carter JM, Kalari KR, Tang X, McLaughlin SA, Moreno-Aspitia A, Northfelt DW, Gray RJ, Hunt KN, Conners AL, Ingle JN, Moyer A, Weinshilboum R, Copland JA 3rd, Wang L, Goetz MP. Boughey JC, et al. Among authors: copland ja 3rd. Clin Cancer Res. 2021 Sep 1;27(17):4696-4699. doi: 10.1158/1078-0432.CCR-21-0641. Epub 2021 Jun 2. Clin Cancer Res. 2021. PMID: 34078650 Free PMC article.
17 results